Research To Practice | Oncology Videos

View Top 200 Chart

Back to Rankings Page

Science
**Research To Practice | Oncology Videos**

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.

Latest Episodes:

Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan Apr 07, 2026

Show notes

Featuring an interview with Dr Ravin Ratan, including the following topics:

Case: A woman in her early 40s who develops intense nausea and vomiting and is diagnosed with a pelvic desmoid tumor elects surveillance and experiences spontaneous regression of the tumor (0:00)
Case: A woman in her late 30s with a painful desmoid tumor in the right pelvic wall receives cryoablation because of concerns about ovarian function (6:49)
Case: A woman in her early 40s with breast implants and multiple resections of breast desmoid tumors receives nirogacestat for 2 years with positive response but develops mucositis and Grade 1 asthenia and stops treatment (14:10)
Case: A woman in her mid 30s with a history of gastric sleeve and endometriosis presents with a painful desmoid tumor in the left upper quadrant, receives nirogacestat with headaches and gastrointestinal symptoms that improve over time and experiences a decrease in tumor size (21:27)

CME information and select publications

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium Apr 03, 2026

Show notes

Featuring perspectives from Dr Jaffer A Ajani, Dr Samuel J Klempner, Dr Rutika Mehta and Dr John Strickler, moderated by Dr Klempner, including the following topics:

Older patient with metastatic claudin 18.2-positive gastroesophageal (GE) cancer (0:00)
Management of nausea and vomiting with zolbetuximab for GE cancer (9:37)
Younger patient with metastatic claudin 18.2-positive, PD-L1-positive GE cancer (15:34)

CME information and select publications

Nonmelanoma Skin Cancers — A Roundtable Discussion on the Multidisciplinary Management of Cutaneous Squamous Cell and Basal Cell Carcinomas Apr 02, 2026

Show notes

Featuring slide presentations and related discussion from Dr Nikhil I Khushalani, Dr Soo J Park, Dr Vishal Anil Patel and Dr Evan Wuthrick, including the following topics:

Introduction (0:00)
Current Management of Localized, Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) (9:55)
Case: A man in his early 70s with cSCC who previously underwent surgery and adjuvant therapy (32:39)
Case: A man in his early 60s with cSCC who receives cemiplimab (54:45)
Incorporation of Radiation Therapy into the Multidisciplinary Management of cSCC and Basal Cell Carcinoma (BCC) (1:04:24)
Case: A man in his early 70s with cSCC who receives radiation therapy after a surgeon expresses concern about the risks of surgery (1:22:15)
Case: A man in his late 80s with cSCC who is not a candidate for surgery (1:24:09)
Evidence-Based Treatment Strategies for Patients with BCC (1:26:00)
Case: A man in his mid sixties with BCC who receives sonidegib (1:36:49)
Case: A man in his late 70s with BCC who receives vismodegib (1:38:32)
Dermatologic Care for Patients with cSCC and BCC (1:45:09)

CME information and select publications

Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review Apr 01, 2026

Show notes

Featuring an interview with Dr Hanny Al-Samkari, including the following topics:

Case: A man in his early 40s with chronic immune thrombocytopenia (ITP) receives romiplostim with rituximab — Bhavana (Tina) Bhatnagar, DO (0:00)
Case: A woman in her early 80s with metastatic adenocarcinoma of the lung responds to carboplatin/pemetrexed/pembrolizumab but after 14 months of maintenance pembrolizumab presents with ITP — Susmitha Apuri, MD (6:48)
Case: A man in his late 70s with a 30-year history of chronic ITP who received corticosteroids and rituximab now receives avatrombopag — Sunil Gandhi, MD (12:06)
Case: A woman in her early 80s with multiple comorbidities and a long history of ITP presents with confusion and fluid retention due to exacerbated congestive heart failure and receives fostamatinib — Dr Bhatnagar (19:26)

CME information and select publications

AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium Mar 30, 2026

Show notes

Featuring perspectives from Prof Karim Fizazi and Dr Daniel George, moderated by Dr Elisabeth I Heath, including the following topics:

Introduction (0:00)
Clinical Implications of and Appropriate Strategies to Identify PTEN Deficiency in Prostate Cancer — Dr George (3:25)
Targeting AKT in Metastatic Prostate Cancer — Prof Fizazi (32:54)
Tolerability and Other Practical Considerations with Capivasertib — Dr Heath (1:03:15)

CME information and select publications

Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway Mar 28, 2026

Show notes

Featuring perspectives from Ms Jamie Carroll, Prof Giuseppe Curigliano, Dr Marie E McDonnell and Dr Hope S Rugo, including the following topics:

Introduction: Use of On-Body Glucose Monitoring Devices (0:00)
Overview of Breast Cancer and Diabetes (9:39)
PI3K/AKT/mTOR Pathway and Glucose Metabolism (19:28)
Case Presentations — Part 1 (26:02)
Current Data with Alpelisib, Capivasertib and Inavolisib (43:51)
Prevention and Management of Hyperglycemia (1:02:17)
Case Presentations — Part 2 (1:10:24)

CME information and select publications

Metastatic Bladder Cancer — Rapid Case Review Issue 3 Mar 27, 2026

Show notes

Featuring patient case presentations by Dr Jacqueline T Brown and Dr Nazli Dizman, with commentary from Dr Matthew Milowsky, including the following topics:

Case: A man in his mid 50s with metastatic recurrence of urothelial bladder cancer (UBC) after neoadjuvant cisplatin/gemcitabine receives first-line enfortumab vedotin (EV)/pembrolizumab (0:00)
Case: A man in his early 50s with muscle-invasive bladder cancer (MIBC) receives adjuvant pembrolizumab, experiences disease progression and then receives EV monotherapy (12:33)
Case: A man in his late 80s with recurrent metastatic UBC after pembrolizumab therapy for MIBC receives EV monotherapy at a reduced dose (24:07)

CME information and select publications

Localized Colorectal Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium Mar 26, 2026

Show notes

Featuring perspectives from Dr Stacey A Cohen, Dr Christopher Lieu and Dr Jenny Seligmann, moderated by Dr Lieu, including the following topics:

Neoadjuvant immunotherapy for localized rectal cancer (0:00)
Surveillance in neoadjuvant immunotherapy for localized rectal cancer (8:14)
Determining a treatment strategy for resectable colon cancer (12:35)

CME information and select publications

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium Mar 25, 2026

Show notes

Featuring perspectives from Dr Matthew D Galsky, Dr Shilpa Gupta, Dr Terence Friedlander and Prof Andrea Necchi, moderated by Dr Friedlander, including the following topics:

Introduction (0:00)
Optimal Use of Anti-PD-1/PD-L1 Antibodies in Non-Muscle-Invasive Bladder Cancer — Dr Friedlander (2:27)
Evolving Management of Muscle-Invasive Bladder Cancer — Dr Gupta (33:30)
Current and Future Role of Novel Intravesical Therapies in Nonmetastatic Urothelial Bladder Cancer (UBC) — Prof Necchi (1:01:56)
Emerging Utility of Circulating Tumor DNA Evaluation in Nonmetastatic UBC — Dr Galsky (1:32:47)

CME information and select publications

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium Mar 24, 2026

Show notes

Featuring perspectives from Dr Jaffer A Ajani, Dr Samuel J Klempner, Dr Rutika Mehta and Dr John Strickler, moderated by Dr Klempner, including the following topics:

Younger patient with metastatic HER2-positive, PD-L1-positive gastric cancer (0:00)
Older patient with metastatic HER2-positive gastroesophageal (GE) cancer (8:13)
Clinical applications for zanidatamab in GE cancer (13:58)

CME information and select publications

Our TOPPODCAST Picks

Follow Us

Stay Connected

Research To Practice | Oncology Videos

Related Podcasts

Links

Stay Connected